JP2008533137A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008533137A5 JP2008533137A5 JP2008501840A JP2008501840A JP2008533137A5 JP 2008533137 A5 JP2008533137 A5 JP 2008533137A5 JP 2008501840 A JP2008501840 A JP 2008501840A JP 2008501840 A JP2008501840 A JP 2008501840A JP 2008533137 A5 JP2008533137 A5 JP 2008533137A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- oxo
- dihydropyridine
- carboxamide
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 2
- 239000012038 nucleophile Substances 0.000 claims description 2
- -1 C 1 -C 6 alkoxy Chemical group 0.000 claims 14
- 229910052739 hydrogen Inorganic materials 0.000 claims 13
- 229910052799 carbon Inorganic materials 0.000 claims 10
- 125000001153 fluoro group Chemical group F* 0.000 claims 9
- 229910052760 oxygen Inorganic materials 0.000 claims 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 6
- 239000001301 oxygen Substances 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims 5
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 4
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 4
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims 4
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- 239000011593 sulfur Substances 0.000 claims 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 2
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 2
- DMVJCLKVSSYLLR-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 DMVJCLKVSSYLLR-UHFFFAOYSA-N 0.000 claims 2
- ZUIQRLIQXYYXHV-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfonyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 ZUIQRLIQXYYXHV-UHFFFAOYSA-N 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 201000003883 Cystic fibrosis Diseases 0.000 claims 2
- 206010014561 Emphysema Diseases 0.000 claims 2
- 108010028275 Leukocyte Elastase Proteins 0.000 claims 2
- 102000016799 Leukocyte elastase Human genes 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 2
- 206010063837 Reperfusion injury Diseases 0.000 claims 2
- 208000027418 Wounds and injury Diseases 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 230000009286 beneficial effect Effects 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 201000009267 bronchiectasis Diseases 0.000 claims 2
- 206010006451 bronchitis Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 150000003857 carboxamides Chemical class 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 230000006378 damage Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 230000002496 gastric effect Effects 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 208000012947 ischemia reperfusion injury Diseases 0.000 claims 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 208000002815 pulmonary hypertension Diseases 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 206010039083 rhinitis Diseases 0.000 claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- GOWJROQOWDMVBZ-UHFFFAOYSA-N 1-(3-cyanophenyl)-5-(4-cyanophenyl)sulfinyl-6-methyl-n-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxopyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C#N)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=N1 GOWJROQOWDMVBZ-UHFFFAOYSA-N 0.000 claims 1
- GYRJKDOPJGUSPE-UHFFFAOYSA-N 2-methyl-5-[(4-methylsulfonylphenyl)methylcarbamoyl]-6-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-sulfonic acid Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(O)(=O)=O)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 GYRJKDOPJGUSPE-UHFFFAOYSA-N 0.000 claims 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims 1
- NSALXVMPIBZHHT-UHFFFAOYSA-N 5-(1h-imidazol-2-ylsulfinyl)-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2NC=CN=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 NSALXVMPIBZHHT-UHFFFAOYSA-N 0.000 claims 1
- MOTBECWQPPQDPL-UHFFFAOYSA-N 5-(2-cyanoethylsulfinyl)-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)CCC#N)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 MOTBECWQPPQDPL-UHFFFAOYSA-N 0.000 claims 1
- PAUGBMUDHIDLFV-UHFFFAOYSA-N 5-(4-acetamidophenyl)sulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1S(=O)C1=C(C)N(C=2C=C(C=CC=2)C(F)(F)F)C(=O)C(C(=O)NCC=2C=CC(=CC=2)S(C)(=O)=O)=C1 PAUGBMUDHIDLFV-UHFFFAOYSA-N 0.000 claims 1
- YBHJQBHCNVLBBQ-UHFFFAOYSA-N 5-(4-acetamidophenyl)sulfonyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1S(=O)(=O)C1=C(C)N(C=2C=C(C=CC=2)C(F)(F)F)C(=O)C(C(=O)NCC=2C=CC(=CC=2)S(C)(=O)=O)=C1 YBHJQBHCNVLBBQ-UHFFFAOYSA-N 0.000 claims 1
- GSBCDEHBLZCQAA-UHFFFAOYSA-N 5-(4-bromophenyl)sulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(Br)=CC=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 GSBCDEHBLZCQAA-UHFFFAOYSA-N 0.000 claims 1
- HQVWMCRXOFKKGL-UHFFFAOYSA-N 5-(4-bromophenyl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2C=CC(Br)=CC=2)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 HQVWMCRXOFKKGL-UHFFFAOYSA-N 0.000 claims 1
- VOEWILCIPRQUFA-UHFFFAOYSA-N 5-(4-chlorophenyl)sulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(Cl)=CC=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 VOEWILCIPRQUFA-UHFFFAOYSA-N 0.000 claims 1
- MFIIUPQNQHZTRC-UHFFFAOYSA-N 5-(4-chlorophenyl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2C=CC(Cl)=CC=2)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 MFIIUPQNQHZTRC-UHFFFAOYSA-N 0.000 claims 1
- JWLGIQRRJSSKLE-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-1-(3,5-dichlorophenyl)-n,6-dimethyl-2-oxopyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC(Cl)=CC(Cl)=C1 JWLGIQRRJSSKLE-UHFFFAOYSA-N 0.000 claims 1
- HOGMYIXDMNBBIQ-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-1-(3,5-dichlorophenyl)-n-[(5-ethylsulfonylpyridin-2-yl)methyl]-6-methyl-2-oxopyridine-3-carboxamide Chemical compound N1=CC(S(=O)(=O)CC)=CC=C1CNC(=O)C(C1=O)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC(Cl)=CC(Cl)=C1 HOGMYIXDMNBBIQ-UHFFFAOYSA-N 0.000 claims 1
- BYMZOLOJPBOJHJ-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-1-(3,5-difluorophenyl)-n,6-dimethyl-2-oxopyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC(F)=CC(F)=C1 BYMZOLOJPBOJHJ-UHFFFAOYSA-N 0.000 claims 1
- VFGWRXNWVNRFEE-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-1-(3,5-difluorophenyl)-n-[(5-ethylsulfonylpyridin-2-yl)methyl]-6-methyl-2-oxopyridine-3-carboxamide Chemical compound N1=CC(S(=O)(=O)CC)=CC=C1CNC(=O)C(C1=O)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC(F)=CC(F)=C1 VFGWRXNWVNRFEE-UHFFFAOYSA-N 0.000 claims 1
- DCBZAYLUTKGUSY-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-1-(3,5-difluorophenyl)-n-[2-(1h-imidazol-5-yl)ethyl]-6-methyl-2-oxopyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(F)C=C(F)C=2)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NCCC1=CNC=N1 DCBZAYLUTKGUSY-UHFFFAOYSA-N 0.000 claims 1
- GUZFBENKJIRRBH-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-6-methyl-1-(3-methylphenyl)-n-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxopyridine-3-carboxamide Chemical compound CC1=CC=CC(N2C(C(C(=O)NCC=3N=CC(=CC=3)S(C)(=O)=O)=CC(=C2C)S(=O)C=2C=CC(=CC=2)C#N)=O)=C1 GUZFBENKJIRRBH-UHFFFAOYSA-N 0.000 claims 1
- WCELYBQNMDUYPI-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound CC1=C(S(=O)C=2C=CC(=CC=2)C#N)C=C(C(N)=O)C(=O)N1C1=CC=CC(C(F)(F)F)=C1 WCELYBQNMDUYPI-UHFFFAOYSA-N 0.000 claims 1
- YDYDOJWRRZKZGN-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-6-methyl-2-oxo-n-[3-(2-oxopyrrolidin-1-yl)propyl]-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NCCCN1CCCC1=O YDYDOJWRRZKZGN-UHFFFAOYSA-N 0.000 claims 1
- ZMUFJLGATVEKRI-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-6-methyl-2-oxo-n-[3-(triazol-1-yl)propyl]-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NCCCN1C=CN=N1 ZMUFJLGATVEKRI-UHFFFAOYSA-N 0.000 claims 1
- MEYYJMGGAJGVIR-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-6-methyl-n-(2-morpholin-4-ylethyl)-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NCCN1CCOCC1 MEYYJMGGAJGVIR-UHFFFAOYSA-N 0.000 claims 1
- HBSKDMSAWKJSIQ-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-6-methyl-n-[(3-methyl-1,2-oxazol-5-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O1N=C(C)C=C1CNC(=O)C(C1=O)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 HBSKDMSAWKJSIQ-UHFFFAOYSA-N 0.000 claims 1
- YOTZVYMIVMMKGQ-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 YOTZVYMIVMMKGQ-UHFFFAOYSA-N 0.000 claims 1
- OKCGFUAFULANFX-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-(1-hydroxy-2-methylpropan-2-yl)-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound CC1=C(S(=O)C=2C=CC(=CC=2)C#N)C=C(C(=O)NC(C)(C)CO)C(=O)N1C1=CC=CC(C(F)(F)F)=C1 OKCGFUAFULANFX-UHFFFAOYSA-N 0.000 claims 1
- XGSNKZPFXMVDRH-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-(2-hydroxy-2-methylpropyl)-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound CC1=C(S(=O)C=2C=CC(=CC=2)C#N)C=C(C(=O)NCC(C)(C)O)C(=O)N1C1=CC=CC(C(F)(F)F)=C1 XGSNKZPFXMVDRH-UHFFFAOYSA-N 0.000 claims 1
- AXTKOOUFUDKUHQ-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-(2-hydroxyethyl)-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound CC1=C(S(=O)C=2C=CC(=CC=2)C#N)C=C(C(=O)NCCO)C(=O)N1C1=CC=CC(C(F)(F)F)=C1 AXTKOOUFUDKUHQ-UHFFFAOYSA-N 0.000 claims 1
- NNFBDDCXLAIGQL-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-(2-hydroxypropyl)-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NCC(O)C)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 NNFBDDCXLAIGQL-UHFFFAOYSA-N 0.000 claims 1
- KNOFFJVVPUYIBR-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-(2-methoxyethyl)-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NCCOC)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 KNOFFJVVPUYIBR-UHFFFAOYSA-N 0.000 claims 1
- SAAHPVSQWALTKK-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-(2-methoxypropyl)-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NCC(C)OC)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 SAAHPVSQWALTKK-UHFFFAOYSA-N 0.000 claims 1
- KPENYCYTBPQQPN-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-(cyclopropylmethyl)-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NCC1CC1 KPENYCYTBPQQPN-UHFFFAOYSA-N 0.000 claims 1
- AETHKXRZLNJOJN-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-[(1-hydroxycyclopropyl)methyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NCC1(O)CC1 AETHKXRZLNJOJN-UHFFFAOYSA-N 0.000 claims 1
- NNFBDDCXLAIGQL-OAMPWVDCSA-N 5-(4-cyanophenyl)sulfinyl-n-[(2r)-2-hydroxypropyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC[C@H](O)C)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 NNFBDDCXLAIGQL-OAMPWVDCSA-N 0.000 claims 1
- NNFBDDCXLAIGQL-XZRDNQIKSA-N 5-(4-cyanophenyl)sulfinyl-n-[(2s)-2-hydroxypropyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC[C@@H](O)C)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 NNFBDDCXLAIGQL-XZRDNQIKSA-N 0.000 claims 1
- QETUWPSKRBCSAT-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-[(5-ethylsulfonylpyridin-2-yl)methyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound N1=CC(S(=O)(=O)CC)=CC=C1CNC(=O)C(C1=O)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 QETUWPSKRBCSAT-UHFFFAOYSA-N 0.000 claims 1
- LCBOEUGSZHUWCQ-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-[2-(1h-imidazol-5-yl)ethyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NCCC1=CNC=N1 LCBOEUGSZHUWCQ-UHFFFAOYSA-N 0.000 claims 1
- YVQFRUXFDBCFGP-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-cyclopropyl-1-(3,5-difluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(F)C=C(F)C=2)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NC1CC1 YVQFRUXFDBCFGP-UHFFFAOYSA-N 0.000 claims 1
- LARXSFJKOHJCHT-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-cyclopropyl-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#N)C=C1C(=O)NC1CC1 LARXSFJKOHJCHT-UHFFFAOYSA-N 0.000 claims 1
- JWOILNBBBPVEPM-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfinyl-n-ethyl-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NCC)=CC(S(=O)C=2C=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 JWOILNBBBPVEPM-UHFFFAOYSA-N 0.000 claims 1
- BNPZZXVAJZJQBK-UHFFFAOYSA-N 5-(4-cyanophenyl)sulfonyl-n-(1-hydroxy-2-methylpropan-2-yl)-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound CC1=C(S(=O)(=O)C=2C=CC(=CC=2)C#N)C=C(C(=O)NC(C)(C)CO)C(=O)N1C1=CC=CC(C(F)(F)F)=C1 BNPZZXVAJZJQBK-UHFFFAOYSA-N 0.000 claims 1
- ZJXFHYNTOUEDQY-UHFFFAOYSA-N 5-(4-ethylphenyl)sulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1S(=O)C1=C(C)N(C=2C=C(C=CC=2)C(F)(F)F)C(=O)C(C(=O)NCC=2C=CC(=CC=2)S(C)(=O)=O)=C1 ZJXFHYNTOUEDQY-UHFFFAOYSA-N 0.000 claims 1
- KMWSIMGHOJLTST-UHFFFAOYSA-N 5-(4-ethylphenyl)sulfonyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1S(=O)(=O)C1=C(C)N(C=2C=C(C=CC=2)C(F)(F)F)C(=O)C(C(=O)NCC=2C=CC(=CC=2)S(C)(=O)=O)=C1 KMWSIMGHOJLTST-UHFFFAOYSA-N 0.000 claims 1
- PLMCTZFMJOVYTF-UHFFFAOYSA-N 5-(4-ethynylphenyl)sulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#C)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 PLMCTZFMJOVYTF-UHFFFAOYSA-N 0.000 claims 1
- CXFKPPYWLGFUCG-UHFFFAOYSA-N 5-(4-fluorophenyl)sulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(F)=CC=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 CXFKPPYWLGFUCG-UHFFFAOYSA-N 0.000 claims 1
- DCDXMKDDBZQXTO-UHFFFAOYSA-N 5-(4-fluorophenyl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2C=CC(F)=CC=2)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 DCDXMKDDBZQXTO-UHFFFAOYSA-N 0.000 claims 1
- JIGLWGWQRSOWAN-UHFFFAOYSA-N 5-(5-bromopyridin-2-yl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2N=CC(Br)=CC=2)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 JIGLWGWQRSOWAN-UHFFFAOYSA-N 0.000 claims 1
- ITXLHIBZXLFJBG-UHFFFAOYSA-N 5-(5-chloropyridin-2-yl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2N=CC(Cl)=CC=2)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 ITXLHIBZXLFJBG-UHFFFAOYSA-N 0.000 claims 1
- CIDCDUHCQZXNSX-UHFFFAOYSA-N 5-(5-cyanopyridin-2-yl)sulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2N=CC(=CC=2)C#N)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 CIDCDUHCQZXNSX-UHFFFAOYSA-N 0.000 claims 1
- UGZXRLQQNOKYAV-UHFFFAOYSA-N 5-(5-cyanopyridin-2-yl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2N=CC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 UGZXRLQQNOKYAV-UHFFFAOYSA-N 0.000 claims 1
- GEMMPDZRYGNLGB-UHFFFAOYSA-N 5-(5-cyanothiophen-2-yl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2SC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 GEMMPDZRYGNLGB-UHFFFAOYSA-N 0.000 claims 1
- KGVICNXONNHIKH-UHFFFAOYSA-N 5-(6-bromopyridazin-3-yl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2N=NC(Br)=CC=2)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 KGVICNXONNHIKH-UHFFFAOYSA-N 0.000 claims 1
- SRYCFQDYOANLAZ-UHFFFAOYSA-N 5-(6-cyanopyridin-3-yl)sulfinyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2C=NC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 SRYCFQDYOANLAZ-UHFFFAOYSA-N 0.000 claims 1
- ZYPDBTPLYAMCGM-UHFFFAOYSA-N 5-(6-cyanopyridin-3-yl)sulfonyl-n,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)(=O)C=2C=NC(=CC=2)C#N)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 ZYPDBTPLYAMCGM-UHFFFAOYSA-N 0.000 claims 1
- VECUQPROCHNSKD-UHFFFAOYSA-N 5-(benzenesulfinyl)-2-oxo-n-[3-(2-oxopyrrolidin-1-yl)propyl]-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound FC(F)(F)C1=CC=CC(N2C(C(C(=O)NCCCN3C(CCC3)=O)=CC(=C2)S(=O)C=2C=CC=CC=2)=O)=C1 VECUQPROCHNSKD-UHFFFAOYSA-N 0.000 claims 1
- NULYXYLATLMXMU-UHFFFAOYSA-N 5-(benzenesulfinyl)-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC=CC=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 NULYXYLATLMXMU-UHFFFAOYSA-N 0.000 claims 1
- LMQGLTVXHNSKPT-UHFFFAOYSA-N 5-(benzenesulfinyl)-n-[(5-cyclopropylsulfonylpyridin-2-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound FC(F)(F)C1=CC=CC(N2C(C(C(=O)NCC=3N=CC(=CC=3)S(=O)(=O)C3CC3)=CC(=C2)S(=O)C=2C=CC=CC=2)=O)=C1 LMQGLTVXHNSKPT-UHFFFAOYSA-N 0.000 claims 1
- GQLHIVRSJRCDMO-UHFFFAOYSA-N 5-(benzenesulfinyl)-n-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NC)=CC(S(=O)C=2C=CC=CC=2)=CN1C1=CC=CC(C(F)(F)F)=C1 GQLHIVRSJRCDMO-UHFFFAOYSA-N 0.000 claims 1
- MJAGNYSUDIDSHS-UHFFFAOYSA-N 5-(benzenesulfonyl)-2-oxo-n-[3-(2-oxopyrrolidin-1-yl)propyl]-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound FC(F)(F)C1=CC=CC(N2C(C(C(=O)NCCCN3C(CCC3)=O)=CC(=C2)S(=O)(=O)C=2C=CC=CC=2)=O)=C1 MJAGNYSUDIDSHS-UHFFFAOYSA-N 0.000 claims 1
- HKJSUEZLKNIFBH-UHFFFAOYSA-N 5-(benzenesulfonyl)-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)(=O)C=2C=CC=CC=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 HKJSUEZLKNIFBH-UHFFFAOYSA-N 0.000 claims 1
- NTGOBSLPRKMKEJ-UHFFFAOYSA-N 5-[(2,4-dimethoxyphenyl)methylsulfinyl]-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound COC1=CC(OC)=CC=C1CS(=O)C1=C(C)N(C=2C=C(C=CC=2)C(F)(F)F)C(=O)C(C(=O)NCC=2C=CC(=CC=2)S(C)(=O)=O)=C1 NTGOBSLPRKMKEJ-UHFFFAOYSA-N 0.000 claims 1
- BFOALPJZJCQFPT-UHFFFAOYSA-N 5-[2-cyanoethyl(methyl)sulfamoyl]-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)(=O)N(CCC#N)C)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 BFOALPJZJCQFPT-UHFFFAOYSA-N 0.000 claims 1
- YCZRHOLCPCKBRI-UHFFFAOYSA-N 5-benzylsulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)CC=2C=CC=CC=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 YCZRHOLCPCKBRI-UHFFFAOYSA-N 0.000 claims 1
- MWCQLOAQHBUEMJ-UHFFFAOYSA-N 5-cyclohexylsulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C2CCCCC2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 MWCQLOAQHBUEMJ-UHFFFAOYSA-N 0.000 claims 1
- XLSHSXQXFATNFC-UHFFFAOYSA-N 5-cyclopropylsulfonyl-n-[(4-cyclopropylsulfonylphenyl)methyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)(=O)C2CC2)C=C1C(=O)NCC(C=C1)=CC=C1S(=O)(=O)C1CC1 XLSHSXQXFATNFC-UHFFFAOYSA-N 0.000 claims 1
- LBVGHQVONDHVSL-UHFFFAOYSA-N 5-ethylsulfinyl-6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)CC)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 LBVGHQVONDHVSL-UHFFFAOYSA-N 0.000 claims 1
- CRANXOCXSWSZPZ-UHFFFAOYSA-N 6-methyl-5-(4-methylphenyl)sulfinyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound C1=CC(C)=CC=C1S(=O)C1=C(C)N(C=2C=C(C=CC=2)C(F)(F)F)C(=O)C(C(=O)NCC=2C=CC(=CC=2)S(C)(=O)=O)=C1 CRANXOCXSWSZPZ-UHFFFAOYSA-N 0.000 claims 1
- OKLVQAFLYLIJFE-UHFFFAOYSA-N 6-methyl-5-methylsulfinyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(C)=O)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 OKLVQAFLYLIJFE-UHFFFAOYSA-N 0.000 claims 1
- QEMUHBARTAOSEA-UHFFFAOYSA-N 6-methyl-5-methylsulfinyl-n-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(C)=O)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=N1 QEMUHBARTAOSEA-UHFFFAOYSA-N 0.000 claims 1
- BXMASAQWMVRPHL-UHFFFAOYSA-N 6-methyl-5-methylsulfonyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(C)(=O)=O)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 BXMASAQWMVRPHL-UHFFFAOYSA-N 0.000 claims 1
- UBWGDMLOYATERU-UHFFFAOYSA-N 6-methyl-5-methylsulfonyl-n-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(C)(=O)=O)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=N1 UBWGDMLOYATERU-UHFFFAOYSA-N 0.000 claims 1
- HMBACIQWRCCXEF-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-5-[4-(2-trimethylsilylethynyl)phenyl]sulfinylpyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#C[Si](C)(C)C)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 HMBACIQWRCCXEF-UHFFFAOYSA-N 0.000 claims 1
- ZCAJIBYGNCPRPE-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-5-[4-(trifluoromethyl)phenyl]sulfinylpyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C(F)(F)F)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 ZCAJIBYGNCPRPE-UHFFFAOYSA-N 0.000 claims 1
- NNFLYBJBYRNWKA-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-5-(phenylsulfamoyl)-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)(=O)NC=2C=CC=CC=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 NNFLYBJBYRNWKA-UHFFFAOYSA-N 0.000 claims 1
- YHIMCPMMQPBITK-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-5-(pyridin-3-ylsulfamoyl)-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)(=O)NC=2C=NC=CC=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 YHIMCPMMQPBITK-UHFFFAOYSA-N 0.000 claims 1
- VWEZEKQXFAVZLF-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-5-[4-(2-phenylethynyl)phenyl]sulfinyl-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)C#CC=2C=CC=CC=2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 VWEZEKQXFAVZLF-UHFFFAOYSA-N 0.000 claims 1
- PWKXYFJXFJCGNY-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-2-oxo-5-phenylsulfanyl-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound C1=C(C(=O)NCC=2C=CC(=CC=2)S(C)(=O)=O)C(=O)N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C1SC1=CC=CC=C1 PWKXYFJXFJCGNY-UHFFFAOYSA-N 0.000 claims 1
- LCJQCVCWQQZQKQ-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-5-(2-morpholin-4-ylethylsulfamoyl)-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)(=O)NCCN2CCOCC2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 LCJQCVCWQQZQKQ-UHFFFAOYSA-N 0.000 claims 1
- YAHKCHATAMSFNY-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-5-(4-nitrophenyl)sulfinyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(=CC=2)[N+]([O-])=O)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 YAHKCHATAMSFNY-UHFFFAOYSA-N 0.000 claims 1
- WXXVHEFUVLYQHK-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-5-[(6-morpholin-4-ylpyridin-3-yl)sulfamoyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)(=O)NC=2C=NC(=CC=2)N2CCOCC2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 WXXVHEFUVLYQHK-UHFFFAOYSA-N 0.000 claims 1
- CVXOLEYXDPSSGL-UHFFFAOYSA-N 6-methyl-n-[(4-methylsulfonylphenyl)methyl]-5-morpholin-4-ylsulfonyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)(=O)N2CCOCC2)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=C1 CVXOLEYXDPSSGL-UHFFFAOYSA-N 0.000 claims 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical class [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000012039 electrophile Substances 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-M isobutyrate Chemical compound CC(C)C([O-])=O KQNPFQTWMSNSAP-UHFFFAOYSA-M 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- FDQIEFBODPCMRQ-UHFFFAOYSA-N n-(cyanomethyl)-5-(4-cyanophenyl)sulfinyl-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound CC1=C(S(=O)C=2C=CC(=CC=2)C#N)C=C(C(=O)NCC#N)C(=O)N1C1=CC=CC(C(F)(F)F)=C1 FDQIEFBODPCMRQ-UHFFFAOYSA-N 0.000 claims 1
- OUYLUTJYQNUBIV-UHFFFAOYSA-N n-[(3-cyclopropyl-1,2-oxazol-5-yl)methyl]-6-methyl-5-methylsulfonyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(C)(=O)=O)C=C1C(=O)NCC(ON=1)=CC=1C1CC1 OUYLUTJYQNUBIV-UHFFFAOYSA-N 0.000 claims 1
- HZOCRWFJLGLRPR-UHFFFAOYSA-N n-cyclopropyl-5-(2-methoxyphenyl)sulfinyl-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound COC1=CC=CC=C1S(=O)C1=C(C)N(C=2C=C(C=CC=2)C(F)(F)F)C(=O)C(C(=O)NC2CC2)=C1 HZOCRWFJLGLRPR-UHFFFAOYSA-N 0.000 claims 1
- NBCHIWYIRUJPCR-UHFFFAOYSA-N n-cyclopropyl-5-(3-methoxyphenyl)sulfinyl-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound COC1=CC=CC(S(=O)C2=C(N(C(=O)C(C(=O)NC3CC3)=C2)C=2C=C(C=CC=2)C(F)(F)F)C)=C1 NBCHIWYIRUJPCR-UHFFFAOYSA-N 0.000 claims 1
- ZLDBSHVEJPXILC-UHFFFAOYSA-N n-cyclopropyl-5-(4-hydroxyphenyl)sulfinyl-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(S(=O)C=2C=CC(O)=CC=2)C=C1C(=O)NC1CC1 ZLDBSHVEJPXILC-UHFFFAOYSA-N 0.000 claims 1
- QHGWPGMJSDTJPC-UHFFFAOYSA-N n-cyclopropyl-5-(4-methoxyphenyl)sulfinyl-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1S(=O)C1=C(C)N(C=2C=C(C=CC=2)C(F)(F)F)C(=O)C(C(=O)NC2CC2)=C1 QHGWPGMJSDTJPC-UHFFFAOYSA-N 0.000 claims 1
- BNHQQOLRIMDHNM-UHFFFAOYSA-N n-ethyl-5-(4-fluorophenyl)sulfinyl-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1C(C(=O)NCC)=CC(S(=O)C=2C=CC(F)=CC=2)=C(C)N1C1=CC=CC(C(F)(F)F)=C1 BNHQQOLRIMDHNM-UHFFFAOYSA-N 0.000 claims 1
- 229960003966 nicotinamide Drugs 0.000 claims 1
- 235000005152 nicotinamide Nutrition 0.000 claims 1
- 239000011570 nicotinamide Substances 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 0 **N(*)C(C1=C(*)C(I=N)=C(*)N(*)C1=O)=O Chemical compound **N(*)C(C1=C(*)C(I=N)=C(*)N(*)C1=O)=O 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0500604 | 2005-03-16 | ||
| PCT/SE2006/000328 WO2006098684A1 (en) | 2005-03-16 | 2006-03-14 | Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008533137A JP2008533137A (ja) | 2008-08-21 |
| JP2008533137A5 true JP2008533137A5 (enExample) | 2009-04-16 |
Family
ID=36991969
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008501840A Pending JP2008533137A (ja) | 2005-03-16 | 2006-03-14 | 好中球エラスターゼインヒビターとしての２−ピリジン誘導体 |
| JP2008501839A Pending JP2008533136A (ja) | 2005-03-16 | 2006-03-14 | 好中球エラスターゼの阻害剤としての２−ピリジン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008501839A Pending JP2008533136A (ja) | 2005-03-16 | 2006-03-14 | 好中球エラスターゼの阻害剤としての２−ピリジン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20090131483A1 (enExample) |
| EP (2) | EP1861370A1 (enExample) |
| JP (2) | JP2008533137A (enExample) |
| KR (1) | KR20070114154A (enExample) |
| CN (2) | CN101142188A (enExample) |
| AR (1) | AR053180A1 (enExample) |
| AU (1) | AU2006223675B2 (enExample) |
| BR (1) | BRPI0608636A2 (enExample) |
| CA (1) | CA2600038A1 (enExample) |
| IL (1) | IL184842A0 (enExample) |
| MX (1) | MX2007009372A (enExample) |
| NO (1) | NO20075059L (enExample) |
| RU (1) | RU2007134106A (enExample) |
| SA (1) | SA06270055B1 (enExample) |
| TW (1) | TW200700392A (enExample) |
| UY (1) | UY29420A1 (enExample) |
| WO (2) | WO2006098683A1 (enExample) |
| ZA (1) | ZA200706761B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0302486D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| TW200808771A (en) * | 2006-05-08 | 2008-02-16 | Astrazeneca Ab | Novel compounds II |
| TW200808763A (en) | 2006-05-08 | 2008-02-16 | Astrazeneca Ab | Novel compounds I |
| JP5483880B2 (ja) * | 2006-10-23 | 2014-05-07 | 武田薬品工業株式会社 | イミノピリジン誘導体およびその用途 |
| WO2009037413A1 (en) * | 2007-09-19 | 2009-03-26 | Argenta Discovery Limited | Dimers of 5- [ (4-cyanophenyl) sulfinyl] -6-methyl-2-oxo-1- [3- (trifluoromethyl)phenyl] -1,2-dihydropyridine-3-carboxamide as inhibitors of human neutrophil elastase for treating respiratory diseases |
| WO2009058076A1 (en) * | 2007-11-02 | 2009-05-07 | Astrazeneca Ab | 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| WO2009061271A1 (en) | 2007-11-06 | 2009-05-14 | Astrazeneca Ab | Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| KR20100130235A (ko) * | 2008-04-23 | 2010-12-10 | 다케다 야쿠힌 고교 가부시키가이샤 | 이미노피리딘 유도체 및 이의 용도 |
| US8481569B2 (en) * | 2008-04-23 | 2013-07-09 | Takeda Pharmaceutical Company Limited | Iminopyridine derivatives and use thereof |
| US20110039892A1 (en) * | 2008-04-23 | 2011-02-17 | Takeda Pharmaceutical Company Limited | Iminopyridine derivative and use thereof |
| GEP20135793B (en) | 2008-09-11 | 2013-03-25 | Pfizer | Heteroaryls amide derivatives and their use as glucokinase activators |
| JP2012515760A (ja) | 2009-01-20 | 2012-07-12 | ファイザー・インク | 置換ピラジノンアミド |
| TW201036957A (en) | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
| WO2010103437A1 (en) | 2009-03-11 | 2010-09-16 | Pfizer Inc. | Benzofuranyl derivatives used as glucokinase inhibitors |
| AU2010302420B2 (en) * | 2009-10-02 | 2013-07-04 | Astrazeneca Ab | 2-pyridone compounds used as inhibitors of neutrophil elastase |
| EP2820017B1 (en) * | 2012-03-02 | 2016-12-21 | Genentech, Inc. | Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
| US20140057920A1 (en) | 2012-08-23 | 2014-02-27 | Boehringer Ingelheim International Gmbh | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| US9102624B2 (en) | 2012-08-23 | 2015-08-11 | Boehringer Ingelheim International Gmbh | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| US20140057926A1 (en) | 2012-08-23 | 2014-02-27 | Boehringer Ingelheim International Gmbh | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| MA43940A (fr) | 2015-09-02 | 2018-12-12 | Glaxosmithkline Ip No 2 Ltd | Dicarboxamide de pyridinone utilisé comme inhibiteur de bromodomaine |
| CN111683976B (zh) | 2018-02-05 | 2022-11-18 | 生物辐射实验室股份有限公司 | 具有阴离子交换-疏水混合模式配体的色谱树脂 |
| AU2020349353A1 (en) | 2019-09-17 | 2022-04-14 | Duke University | Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease |
| HUE064089T2 (hu) | 2020-04-16 | 2024-02-28 | Mereo Biopharma 4 Ltd | Alvelesztat neutrofil elasztáz inhibitort alkalmazó módszerek alfa-1-antitripszin hiány által közvetített légzõszervi megbetegedés kezelésére |
| AU2022373971A1 (en) | 2021-10-20 | 2024-04-04 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2706977A1 (de) * | 1977-02-18 | 1978-08-24 | Hoechst Ag | Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung |
| US5521179A (en) * | 1991-04-18 | 1996-05-28 | Zeneca Limited | Heterocyclic amides |
| US5441960A (en) * | 1992-04-16 | 1995-08-15 | Zeneca Limited | 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
| IL131493A (en) * | 1997-03-04 | 2004-05-12 | Monsanto Co | Aromatic compounds of the hydroxamic sulfonyl alpha-deroxamic acid and their use in the preparation of drugs for the treatment of a condition associated with pathological activity of the metalloprotease matrix |
| WO2001096308A1 (en) * | 2000-06-12 | 2001-12-20 | Eisai Co., Ltd. | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| DE60139506D1 (de) * | 2000-12-28 | 2009-09-17 | Shionogi & Co | 2-pyridonderivate mit affinität für den cannabinoid-typ-2-rezeptor |
| GB0129260D0 (en) * | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
| US7230017B2 (en) * | 2002-08-27 | 2007-06-12 | Bayer Healthcare Ag | Dihydropyridinone derivatives |
| TW200500341A (en) * | 2002-11-12 | 2005-01-01 | Astrazeneca Ab | Novel compounds |
| SE0302324D0 (sv) * | 2003-08-28 | 2003-08-28 | Astrazeneca Ab | Novel compounds |
| SE0302323D0 (sv) * | 2003-08-28 | 2003-08-28 | Astrazeneca Ab | Novel compounds |
| SE0302486D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| SE0302487D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
-
2006
- 2006-03-06 TW TW095107354A patent/TW200700392A/zh unknown
- 2006-03-14 CN CNA2006800085427A patent/CN101142188A/zh active Pending
- 2006-03-14 US US11/908,746 patent/US20090131483A1/en not_active Abandoned
- 2006-03-14 KR KR1020077021054A patent/KR20070114154A/ko not_active Withdrawn
- 2006-03-14 SA SA06270055A patent/SA06270055B1/ar unknown
- 2006-03-14 MX MX2007009372A patent/MX2007009372A/es not_active Application Discontinuation
- 2006-03-14 CA CA002600038A patent/CA2600038A1/en not_active Abandoned
- 2006-03-14 BR BRPI0608636-5A patent/BRPI0608636A2/pt not_active IP Right Cessation
- 2006-03-14 CN CNA2006800085728A patent/CN101142189A/zh active Pending
- 2006-03-14 EP EP06717012A patent/EP1861370A1/en not_active Withdrawn
- 2006-03-14 WO PCT/SE2006/000327 patent/WO2006098683A1/en not_active Ceased
- 2006-03-14 RU RU2007134106/04A patent/RU2007134106A/ru not_active Application Discontinuation
- 2006-03-14 EP EP06717013A patent/EP1861371A4/en not_active Withdrawn
- 2006-03-14 US US11/908,748 patent/US20090105239A1/en not_active Abandoned
- 2006-03-14 WO PCT/SE2006/000328 patent/WO2006098684A1/en not_active Ceased
- 2006-03-14 JP JP2008501840A patent/JP2008533137A/ja active Pending
- 2006-03-14 AU AU2006223675A patent/AU2006223675B2/en not_active Ceased
- 2006-03-14 JP JP2008501839A patent/JP2008533136A/ja active Pending
- 2006-03-15 UY UY29420A patent/UY29420A1/es unknown
- 2006-03-16 AR ARP060101041A patent/AR053180A1/es unknown
-
2007
- 2007-07-26 IL IL184842A patent/IL184842A0/en unknown
- 2007-08-14 ZA ZA200706761A patent/ZA200706761B/xx unknown
- 2007-10-08 NO NO20075059A patent/NO20075059L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007134106A (ru) | Новые соединения ii, являющиеся производными 2-пиридина, в качестве ингибиторов | |
| CA2476343A1 (en) | 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors | |
| RU2008144571A (ru) | Пиридиламидные антагонисты кальциевых каналов т-типа | |
| EP1434773B1 (en) | Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 | |
| JP4053877B2 (ja) | ４−フェニル−ピリジン誘導体 | |
| JP2019533694A5 (enExample) | ||
| JP5667297B2 (ja) | ヘテロアリールメチルアミド | |
| JP2004506632A5 (enExample) | ||
| JP2004504301A5 (enExample) | ||
| JP2009536196A5 (enExample) | ||
| JP2007505901A5 (enExample) | ||
| JP2010515691A5 (enExample) | ||
| JP2009536197A5 (enExample) | ||
| JP2006500369A5 (enExample) | ||
| RU2016102313A (ru) | Биарильные производные в качестве агонистов gpr120 | |
| JP2009517383A (ja) | 新規な３−ビシクロカルボニルアミノピリジン−２−カルボキサミド又は３−ビシクロカルボニルアミノピラジン−２−カルボキサミド | |
| JP2004521095A5 (enExample) | ||
| NO339260B1 (no) | Pyridylforbindelser som inhiberer hedgehog-signalveien, fremgangsmåte for fremstilling derav, preparat der av, anvendelse derav for fremstilling av et medikament for behandling av kreft eller inhibering av angiogenese eller hedgehog-signalveien hos et pattedyr | |
| JP2002080453A5 (enExample) | ||
| EA027780B1 (ru) | Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2 | |
| EP1562902A1 (en) | 2-pyridone derivatives as inhibitors of neutrophile elastase | |
| RU2009125620A (ru) | Органические соединения | |
| RU2004119966A (ru) | N-пиразинил-фенилсульфонамиды и их применение в лечении хемикин- медиированных заболеваний | |
| RU2019117556A (ru) | Индазольные производные, пригодные в качестве ингибиторов диацилглицерид o-ацилтрансферазы 2 | |
| MXPA05009104A (es) | Derivados de urea biciclica novedosa utiles en el tratamiento del cancer y otros trastornos. |